Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS® vs. Custom Made Devices
IRIS
Multicenters, Randomised Clinical Trial, to Evaluate Efficacy and Compliance of Mandibular Advancement Devices ONIRIS® vs. Laboratory Devices TALI in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas
1 other identifier
interventional
211
1 country
10
Brief Summary
To evaluate the efficacy (non-inferiority) in terms of response between patients using custom fitted mandibular advancement devices ONIRIS® and patient using laboratory custom made devices TALI, after 2 months of use. Sleeping tests were performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 12, 2015
CompletedFirst Posted
Study publicly available on registry
January 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2018
CompletedAugust 31, 2018
August 1, 2018
3.3 years
January 12, 2015
August 29, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the efficacity (non-inferiority) in terms of response between patients using mandibular advancement devices ONIRIS® and patient using devices produced in a laboratoryTALI after 2 months of use.
The response to the treatment is defined as: * complete patient response: AHI per hour of sleep \< 10 or * partial patient response: AHI per hour of sleep reduced by 50% at visit M2 compared to baseline
2 monthes of use
Secondary Outcomes (8)
Evolution of AHI, AI and HI
at M2 and at M12
Percentage of patients responder
at M2 and M12
Evolution during the study of the principal criteria concerning the sleep
at baseline, M2, M6 and M12
Evolution of the quality of life
at baseline, M2, M6 and M12
Evolution of the compliance
at M2, M6 and M12
- +3 more secondary outcomes
Study Arms (2)
mandibular advancement devices ONIRIS®
EXPERIMENTALThe patients will use the mandibular advancement devices ONIRIS®
laboratory devices TALI
ACTIVE COMPARATORThe patients will use the laboratory devices TALI
Interventions
Eligibility Criteria
You may qualify if:
- patients with severe syndrome of obstructive sleep apnea and hypopneas refusing or withdrawal from continuous positive pression ventilation
- no dental, paro-dental or articular contraindication
- patients never treated by mandibular advancement devices
You may not qualify if:
- severe psychiatric or neuromuscular disorders appreciated by the investigator
- more than 20% of apneas and central hypoapneas
- severe syndrome of obstructive sleep apnea and hypopneas with IAH \> 30% associated with another sleeping pathology
- BMI \> 30kg/m2
- patient with an uncontrollable nausea reflex
- epileptic patients
- pregnant patients
- patient without written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ONIRISlead
Study Sites (10)
Clinique Bel-Air
Bordeaux, France
Polyclinique Saint Privat
Boujan-sur-Libron, France
CHU de Grenoble
La Tronche, France
Hôpital André Mignot
Le Chesnay, 78157, France
Medical Practice
Les Pavillons-sous-Bois, 93320, France
Medical Practice
Maisons-Alfort, France
CHU Montpellier
Montpellier, France
Fondation Ophtalmologique Adolphe de Rothschild
Paris, France
Medical Practice
Perpignan, France
Centre Cardiologique du Nord
Saint-Denis, France
Related Publications (1)
Pepin JL, Raymond N, Lacaze O, Aisenberg N, Forcioli J, Bonte E, Bourdin A, Launois S, Tamisier R, Molinari N. Heat-moulded versus custom-made mandibular advancement devices for obstructive sleep apnoea: a randomised non-inferiority trial. Thorax. 2019 Jul;74(7):667-674. doi: 10.1136/thoraxjnl-2018-212726. Epub 2019 May 3.
PMID: 31053619DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
RAYMOND Nathalie, MD
Hôpital Bel Air
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2015
First Posted
January 28, 2015
Study Start
January 1, 2015
Primary Completion
April 28, 2018
Study Completion
April 28, 2018
Last Updated
August 31, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share